ORTHO VISION® Analyzer Named Innovation Celebration Award Winner at Premier’s Annual Meeting

ORTHO VISION® Analyzer Named Innovation Celebration Award Winner at Premier’s Annual Meeting

Jun 23, 2016

ORTHO VISION® Analyzer Named Innovation Celebration Award Winner at Premier’s Annual Meeting

June 23, 2016
Health Care Industry Award Recognizes Innovation, Improving Patient Outcomes

RARITAN, NJ, June 23, 2016 – Ortho Clinical Diagnostics (Ortho) today announced that its ORTHO VISION® Analyzer, a fully automated system for use by laboratories that test blood to be used in transfusion medicine, has been recognized with a 2016 Innovation Award by members of Premier, Inc.  Premier is a health care improvement company that unites an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers around the goal of transforming health care.

Premier’s Innovation Celebration takes place during the Breakthroughs Conference and Exhibition in National Harbor, MD.  The event, where the ORTHO VISION Analyzer will be exhibited, recognizes advances in health care while highlighting industry suppliers committed to innovation and improving patient outcomes.

“Ortho shares Premier’s commitment to providing valuable products to our alliance members that are safe, high-quality and cost-effective,” said Durral R. Gilbert, president of supply chain services, Premier. “We believe these innovations can benefit providers as they work to transform health care.”
Ortho is the world leader in immunohematology.  The ORTHO VISION Analyzer automates the full range of immunohematology testing, including serial dilutions for titration studies and selected cell panels, which helps to eliminate the need for manual testing, potentially making the transfusion process safer and more efficient.  Clinicians and other health system members of Premier selected the ORTHO VISION Analyzer to be showcased at the Innovation Celebration because of its uniqueness, impact on unmet clinical needs and potential to improve patient care.

“Ortho is a longtime pioneer in immunohematology, and our purpose is to improve and save lives through diagnostics,” said Robert Bolger Jr., Ortho’s vice president of Corporate Accounts. “We’re honored that Premier has recognized us for developing the ORTHO VISION Analyzer, which has reimagined what’s possible in transfusion medicine for our lab customers worldwide.” 
About Premier, Inc.
Premier Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well as Twitter, FacebookLinkedInYouTubeInstagramFoursquare and Premier’s blog for more information about the company.
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks and labs in more than 120 countries, Ortho’s high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho’s purpose is to improve and save lives with diagnostics, and it does that by reimagining what’s possible. This is what has defined Ortho for more than 75 years, and it’s what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.
ORTHO VISION® Analyzer is a trademark of Ortho Clinical Diagnostics.
© Ortho Clinical Diagnostics 2016
Media Contact: 
Jane Ward, Global External Communications
908-218-8245 (o)
908-210-0118 (m)